Dudediligence.

Aktis Oncology, Inc

AKTSNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 10-Q, Quarterly reportAug 13 →Insiders17 insiders bought $114.3M in 9 open-market buys. No sales.→HoldersMPM Bioimpact 9.0%EcoR1 Capital 9.0%Blue Owl Capital 5.7%→Financing →PeersClosest companies: CATX, BCYC, JANX→

From the filings

Figures

Cash and equivalents
$82.5Mat the last balance sheet
Shares outstanding
53.4M shareson issue
Every year and quarter →